Marker Therapeutics, Inc.

MRKR·NASDAQ·$1.45Share Price as of 11/2·$16MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202503/18/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report10/19/26 8-KCurrent report05/04/26 8-KCurrent report03/19/26 8-KCurrent report02/09/26 8-KCurrent report11/14/25

Prospectuses and Registrations

424B7Prospectus08/05/25 424B3Prospectus01/17/25 S-3Shelf registration01/10/25 424B3Prospectus12/06/24 S-3Shelf registration11/27/24

Proxies

DEF 14ADefinitive proxy03/20/26 DEFA14AAdditional proxy materials03/20/26 PRE 14APreliminary proxy03/10/26 DEF 14ADefinitive proxy04/24/25 DEFA14AAdditional proxy materials04/24/25

Ownership

Form 4Insider transaction11/19/25 Form 4Insider transaction11/19/25 Form 4Insider transaction11/19/25 SC 13D/ABeneficial ownership (amended)11/17/25 SC 13G/ABeneficial ownership (amended)11/14/25

Other

ARSAnnual report to shareholders03/20/26 ARSAnnual report to shareholders04/24/25 EFFECTRequest for effectiveness01/17/25 CORRESPCorrespondence with the SEC01/15/25 UPLOADLetter from the SEC01/15/25